SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (5848)3/9/1998 10:51:00 PM
From: EyeDrMike  Read Replies (1) of 23519
 
<<I agree and that's precisely why Vivus is trading at $ 12 today. The street lacks confidence in Vivus and it's management team>>

Again, i disagree. IMO, the street is pissed at management for 4Q97 and no other reason. Management did not give the analysts a "heads-up" beforehand, and as a result they: cut the forward projections, the EPS estimates, the price, the stock ratings, etc. To solely punish this company.

As soon as the FDA and MCA approvals come, the analysts will be forced to restate estimates and upgrade this stock, for the production capacity problems will be over.

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext